BMCMI
IDXX icon

Bryn Mawr Capital Management Inc’s Idexx Laboratories IDXX Stock Holding History

Bryn Mawr Capital Management Inc’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-37,756
Closed -$2.01M – 599
2013
Q4 		$2.01M Buy
+37,756
New +$1.99M 0.13% 180

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Bryn Mawr Capital Management Inc's IDXX Position: Q1 2014 in Review

Bryn Mawr Capital Management Inc sold out of Idexx Laboratories (IDXX) in Q1 2014, closing a stake of 37,756 shares — an estimated $2.01M sold.

Bryn Mawr Capital Management Inc first reported a position in IDXX in Q4 2013 and held it in 1 quarter. The position peaked at $2.01M in Q4 2013. 314 funds tracked by Wall St. Rank hold IDXX as of Q1 2014.

  • Bryn Mawr Capital Management Inc reported no remaining Idexx Laboratories position as of Q1 2014 after selling out during the quarter.
  • Bryn Mawr Capital Management Inc sold 37,756 Idexx Laboratories shares in Q1 2014, an estimated $2.01M.
  • Bryn Mawr Capital Management Inc first reported a position in Idexx Laboratories in Q4 2013 and held it in 1 quarter.
  • Bryn Mawr Capital Management Inc's Idexx Laboratories position peaked at $2.01M in Q4 2013.
  • 314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2014.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q1 2014, filed 15 May 2014.